<DOC>
	<DOCNO>NCT01851525</DOCNO>
	<brief_summary>Catheter ablation emerge effective therapy atrial fibrillation ( AF ) . However , achievement complete &amp; durable isolation pulmonary vein ( PVs ) challenging , primary limit operator experience also limit currently available ablation technology . Direct contact force sensing ( CFS ) novel technology may help ensure adequate lesion delivery . CFS may also help improve safety profile catheter ablation . The purpose study compare two strategy wide antral PV isolation plus linear ablation persistent AF : 1. guide contact force sensing ( CFS ) OR 2. blind contact force sensing ( CFS ) - i.e . standard approach</brief_summary>
	<brief_title>Therapeutic Outcomes Using Contact Force Handling During Atrial Fibrillation Ablation</brief_title>
	<detailed_description />
	<mesh_term>Atrial Fibrillation</mesh_term>
	<criteria>Inclusion Criteria Age &gt; 18 year . Patients undergoing firsttime catheter ablation AF . Persistent AF define episode great 7 day duration . Symptomatic AF define patient aware AF anytime within last 5 year prior enrolment . Symptoms may include , restrict , palpitation , shortness breath , chest pain , fatigue , leave ventricular dysfunction , symptom , combination . At least one episode AF must document ECG , Holter , loop recorder , telemetry , implanted device , transtelephonic monitoring within 24 month enrolment . Willing able provide inform consent . Exclusion Criteria Paroxysmal AF . AF secondary reversible cause . Patients contraindication systemic anticoagulation heparin , coumadin , direct thrombin inhibitor . Patients previously undergone AF ablation . Patients leave atrial size &gt; 55 mm ( echocardiography , parasternal long axis view ) . Patients may potentially pregnant .</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2014</verification_date>
	<keyword>Atrial fibrillation</keyword>
	<keyword>Ablation</keyword>
</DOC>